Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronac Mamtani

Showing results (41-50 of 198) with videos related to

Pageof 20
Sort By:
Digestive Diseases and Sciences|February 20, 2016
A Risk Prediction Model for Sporadic CRC Based on Routine Lab ResultsBen Boursi, Ronac Mamtani, Wei-Ting Hwang, et al.
American Journal of Hematology|March 9, 2016
Reappraisal of risk factors for monoclonal gammopathy of undetermined significanceBen Boursi, Brendan M Weiss, Kevin Haynes, et al.
Pharmacoepidemiology and Drug Safety|June 7, 2022
Very high PD-L1 expression as a prognostic indicator of overall survival among patients with advanced non-small cell lung cancer receiving anti-PD-(L)1 monotherapies in routine practiceMohsin Shah, Rebecca A Hubbard, Ronac Mamtani, et al.
Cancer Causes & Control : CCC|October 16, 2020
Digoxin use is associated with pancreatic cancer risk but does not affect survivalBen Boursi, Jared S Huber, Kevin Haynes, et al.
Pharmacoepidemiology and Drug Safety|July 8, 2016
Ion channel blockers and glioblastoma risk and outcome: a nested case-control and retrospective cohort studiesBen Boursi, Harry J Han, Kevin Haynes, et al.
JAMA Network Open|June 12, 2025
Second-Line Treatment Strategies for Right-Sided, RAS/RAF Wild-Type Colorectal CancerNishwant Swami, Wei-Ting Hwang, Ronac Mamtani, et al.
Gastroenterology|July 30, 2018
Incidence, Risk Factors, and Clinical Effects of Recurrent Diverticular Hemorrhage: A Large Cohort StudyRavy K Vajravelu, Ronac Mamtani, Frank I Scott, et al.
The Journal of Urology|January 27, 2016
Association of Itraconazole, a Hedgehog Inhibitor, and Bladder CancerRonac Mamtani, Yu-Xiao Yang, Frank I Scott, et al.
JAMA Network Open|January 5, 2022
Outcomes Among African American and Non-Hispanic White Men With Metastatic Castration-Resistant Prostate Cancer With First-Line AbirateroneMallika Marar, Qi Long, Ronac Mamtani, et al.
Pharmacoepidemiology and Drug Safety|December 31, 2013
Distinguishing incident and prevalent diabetes in an electronic medical records databaseRonac Mamtani, Kevin Haynes, Brian S Finkelman, et al.
Pageof 20

Showing results (41-50 of 198) with videos related to

Sort By:
Pageof 20
Digestive Diseases and Sciences|February 20, 2016
A Risk Prediction Model for Sporadic CRC Based on Routine Lab ResultsBen Boursi, Ronac Mamtani, Wei-Ting Hwang, et al.
American Journal of Hematology|March 9, 2016
Reappraisal of risk factors for monoclonal gammopathy of undetermined significanceBen Boursi, Brendan M Weiss, Kevin Haynes, et al.
Pharmacoepidemiology and Drug Safety|June 7, 2022
Very high PD-L1 expression as a prognostic indicator of overall survival among patients with advanced non-small cell lung cancer receiving anti-PD-(L)1 monotherapies in routine practiceMohsin Shah, Rebecca A Hubbard, Ronac Mamtani, et al.
Cancer Causes & Control : CCC|October 16, 2020
Digoxin use is associated with pancreatic cancer risk but does not affect survivalBen Boursi, Jared S Huber, Kevin Haynes, et al.
Pharmacoepidemiology and Drug Safety|July 8, 2016
Ion channel blockers and glioblastoma risk and outcome: a nested case-control and retrospective cohort studiesBen Boursi, Harry J Han, Kevin Haynes, et al.
JAMA Network Open|June 12, 2025
Second-Line Treatment Strategies for Right-Sided, RAS/RAF Wild-Type Colorectal CancerNishwant Swami, Wei-Ting Hwang, Ronac Mamtani, et al.
Gastroenterology|July 30, 2018
Incidence, Risk Factors, and Clinical Effects of Recurrent Diverticular Hemorrhage: A Large Cohort StudyRavy K Vajravelu, Ronac Mamtani, Frank I Scott, et al.
The Journal of Urology|January 27, 2016
Association of Itraconazole, a Hedgehog Inhibitor, and Bladder CancerRonac Mamtani, Yu-Xiao Yang, Frank I Scott, et al.
JAMA Network Open|January 5, 2022
Outcomes Among African American and Non-Hispanic White Men With Metastatic Castration-Resistant Prostate Cancer With First-Line AbirateroneMallika Marar, Qi Long, Ronac Mamtani, et al.
Pharmacoepidemiology and Drug Safety|December 31, 2013
Distinguishing incident and prevalent diabetes in an electronic medical records databaseRonac Mamtani, Kevin Haynes, Brian S Finkelman, et al.
Pageof 20